Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Pediatr Diabetes. 2017 Jan 17;18(8):755–760. doi: 10.1111/pedi.12490

Table 1. Clinical characteristics of study participants according to group.

Patient Characteristic Lean (n = 99) Obese (n = 93) Type 2 diabetes (n = 94) P-Values
Age (years) 20.6 (2.1) 21.1 (2.4) 20.4 (2.2) 0.10
Sex (n, % female) 58 (59) 53 (57) 56 (60) 0.94
Race¥ 0.02
Caucasian(%) 56 47 37
African-American (%) 44 53 62
Other (%) 0 0 2
Medications
Insulin (%) 0 0 40
Oral hypoglycemic (%) 0 0 46
Estrogen containing (%) 4 2 2 0.19
Height (cm) 170.3 ± 7.9 170.7 ± 9.3 169.8 ± 9.7 0.75
Weight (Kg)* 65 (58, 76) 87.5 (75, 100) 107 (83, 126) <0.0001
BMI (kg/m2)# 22 (20.7, 24.6) 30 (27.4, 34.1) 35.4 (30.9, 42.9) <0.0001
Systolic BP (mmHg)# 114 (108, 121) 118 (111, 124) 121 (114, 130) 0.0003
Diastolic BP (mmHg) 69 ± 7 71 ± 6 69 ± 13 0.07
HbA1c (%) 8.7 ± 3.1
HbA1c (mmol/mol) 72 ± 10
Fasting Glucose (mg/dL)* 87 (82, 91) 90 (85, 93) 134 (98, 246) <0.0001
Fasting Insulin (mU/mL)# 11.9 (8.9, 16.0) 16.6 (12.4, 21.2) 17.1 (12.3, 25.9) <0.0001
Total cholesterol (mg/dL)* 160 (141, 183) 156 (143, 181) 177 (157, 216) <0.0001
LDL cholesterol (mg/dL)# 89.5 (75, 108) 88 (77, 109) 112 (90, 137) <0.0001
HDL cholesterol (mg/dL)# 53 (44, 64) 50 (45, 58) 42 (37, 51) <0.0001
Non-HDL cholesterol (mg/dL)# 108 (89, 129) 104 (89, 129) 136 (112, 170) <0.0001
Triglycerides (mg/dL)# 80 (57, 105) 72 (57, 99) 99 (70, 165) <0.0001
CRP (mg/dL)# 0.5 (0.2, 1.6) 1.2 (0.8, 3.0) 3.5 (1, 6.8) <0.0001
PCSK9 (ng/mL)# 239 (210, 312) 284 (229, 363) 288 (226, 391) 0.002

Values are mean ± SD or median (Interquartile Range).

¥

Comparisons between groups using Fisher's Exact Test.

*

Indicates non-normally distributed data; Kruskal-Wallis Test was used for comparisons between groups.

#

Indicates data that was log transformed to achieve normality; one way ANOVA was used for comparisons between groups.